Masimo (MASI) EBT Margin (2009 - 2026)
Masimo's quarterly EBT Margin came in at 17.67% in Q2 2026, down 72.0% year-on-year from 63.09% in Q2 2025, and down 1.52% quarter-over-quarter from 17.94% in Q1 2026.
Masimo has reported EBT Margin for 18 years, with the latest figure at 17.67% in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin fell 72.0% year-over-year to 17.67%; the trailing twelve-month figure through Apr 2026 stood at 17.68% (up 1428.0% YoY), and the FY2026 full-year result was 17.85%, up 1629.0% from the prior year.
- EBT Margin for Q2 2026 stood at 17.67%, down from 17.94% in the prior quarter.
- The five-year high for EBT Margin was 23.62% in Q1 2022, with the low at 21.66% in Q4 2024.
- Average EBT Margin over 5 years is 8.55%, with a median of 9.21% recorded in 2024.
- Year-over-year, EBT Margin tumbled 2947 bps in 2023 and soared 3960 bps in 2026.
- Tracing MASI's EBT Margin over 5 years: stood at 8.02% in 2022, then plunged by 368 bps to 21.46% in 2023, then fell by 1 bps to 21.66% in 2024, then soared by 193 bps to 20.16% in 2025, then dropped by 12 bps to 17.67% in 2026.
- The last three EBT Margin figures came in at 17.67% (Q2 2026), 17.94% (Q1 2026), and 20.16% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.17% |
| 10 | Masimo | 9.32 Bn | 9.20 Bn | 250.80 Mn | 17.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 17.67% |
| Jan 3, 2026 | 17.94% |
| Sep 27, 2025 | 20.16% |
| Jun 28, 2025 | 14.94% |
| Mar 29, 2025 | 18.39% |
| Dec 28, 2024 | -21.66% |
| Sep 28, 2024 | 8.51% |
| Jun 29, 2024 | 8.96% |
| Mar 30, 2024 | 12.22% |
| Dec 30, 2023 | -21.46% |
| Sep 30, 2023 | 2.92% |
| Jul 1, 2023 | 5.45% |
| Apr 1, 2023 | 4.64% |
| Dec 31, 2022 | 8.02% |
| Oct 1, 2022 | 9.47% |
| Jul 2, 2022 | 4.71% |
| Apr 2, 2022 | 19.43% |
| Jan 1, 2022 | 23.62% |
| Oct 2, 2021 | 21.99% |
| Jul 3, 2021 | 21.37% |
| Apr 3, 2021 | 21.71% |
| Jan 2, 2021 | 21.99% |
| Sep 26, 2020 | 21.95% |
| Jun 27, 2020 | 21.14% |
| Mar 28, 2020 | 26.84% |
| Dec 28, 2019 | 26.01% |
| Sep 28, 2019 | 23.73% |
| Jun 29, 2019 | 24.18% |
| Mar 30, 2019 | 25.86% |
| Dec 29, 2018 | 24.90% |
| Sep 29, 2018 | 23.59% |
| Jun 30, 2018 | 25.05% |
| Mar 31, 2018 | 26.08% |
| Dec 30, 2017 | 21.84% |
| Sep 30, 2017 | 22.42% |
| Jul 1, 2017 | 22.88% |
| Apr 1, 2017 | 26.97% |
| Dec 31, 2016 | 176.16% |
| Oct 1, 2016 | 21.51% |
| Jul 2, 2016 | 21.37% |
| Apr 2, 2016 | 22.10% |
| Jan 2, 2016 | 27.21% |
| Oct 3, 2015 | 17.76% |
| Jul 4, 2015 | 17.16% |
| Apr 4, 2015 | 17.81% |
| Jan 3, 2015 | 20.18% |
| Sep 27, 2014 | 15.06% |
| Jun 28, 2014 | 13.29% |
| Mar 29, 2014 | 21.74% |
| Dec 28, 2013 | 8.36% |
| Sep 28, 2013 | 15.27% |
| Jun 29, 2013 | 16.69% |
| Mar 30, 2013 | 15.31% |
| Dec 29, 2012 | 15.89% |
| Sep 29, 2012 | 15.84% |
| Jun 30, 2012 | 18.09% |
| Mar 31, 2012 | 18.24% |
| Dec 31, 2011 | 17.44% |
| Oct 1, 2011 | 17.97% |
| Jul 2, 2011 | 20.68% |
| Apr 2, 2011 | 22.63% |
| Jan 1, 2011 | 43.87% |
| Oct 2, 2010 | 23.83% |
| Jul 3, 2010 | 21.30% |
| Apr 3, 2010 | 40.94% |
| Oct 3, 2009 | 24.17% |
| Jul 4, 2009 | 24.31% |